These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 19643972)
1. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972 [TBL] [Abstract][Full Text] [Related]
2. HSP-27 protein expression in uveal melanoma: correlation with predicted survival. Jmor F; Kalirai H; Taktak A; Damato B; Coupland SE Acta Ophthalmol; 2012 Sep; 90(6):534-9. PubMed ID: 21114636 [TBL] [Abstract][Full Text] [Related]
3. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742 [TBL] [Abstract][Full Text] [Related]
4. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992 [TBL] [Abstract][Full Text] [Related]
5. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Lake SL; Coupland SE; Taktak AF; Damato BE Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121 [TBL] [Abstract][Full Text] [Related]
6. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Tschentscher F; Hüsing J; Hölter T; Kruse E; Dresen IG; Jöckel KH; Anastassiou G; Schilling H; Bornfeld N; Horsthemke B; Lohmann DR; Zeschnigk M Cancer Res; 2003 May; 63(10):2578-84. PubMed ID: 12750282 [TBL] [Abstract][Full Text] [Related]
7. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma. Lake SL; Kalirai H; Dopierala J; Damato BE; Coupland SE Invest Ophthalmol Vis Sci; 2012 May; 53(6):2647-52. PubMed ID: 22427594 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not. Linge A; Kennedy S; O'Flynn D; Beatty S; Moriarty P; Henry M; Clynes M; Larkin A; Meleady P Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4634-43. PubMed ID: 22570344 [TBL] [Abstract][Full Text] [Related]
9. Chromosome 3 intratumor heterogeneity in uveal melanoma. Mensink HW; Vaarwater J; Kiliç E; Naus NC; Mooy N; Luyten G; Brüggenwirth HT; Paridaens D; de Klein A Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):500-4. PubMed ID: 18824727 [TBL] [Abstract][Full Text] [Related]
10. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization. Parrella P; Caballero OL; Sidransky D; Merbs SL Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428 [TBL] [Abstract][Full Text] [Related]
11. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574 [TBL] [Abstract][Full Text] [Related]
12. Cytogenetics of uveal melanoma: a 7-year clinical experience. Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643 [TBL] [Abstract][Full Text] [Related]
13. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status. Shields CL; Bianciotto C; Rudich D; Materin MA; Ganguly A; Shields JA Retina; 2008 Oct; 28(9):1289-95. PubMed ID: 18628721 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005 [TBL] [Abstract][Full Text] [Related]
15. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859 [TBL] [Abstract][Full Text] [Related]
16. Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma. Sisley K; Tattersall N; Dyson M; Smith K; Mudhar HS; Rennie IG Exp Eye Res; 2006 Sep; 83(3):554-9. PubMed ID: 16684523 [TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3. Nareyeck G; Zeschnigk M; Prescher G; Lohmann DR; Anastassiou G Exp Eye Res; 2006 Oct; 83(4):858-64. PubMed ID: 16750193 [TBL] [Abstract][Full Text] [Related]
18. Clinical and cytogenetic analyses in uveal melanoma. Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076 [TBL] [Abstract][Full Text] [Related]
19. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma. Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997 [TBL] [Abstract][Full Text] [Related]
20. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Cross NA; Ganesh A; Parpia M; Murray AK; Rennie IG; Sisley K Eye (Lond); 2006 Apr; 20(4):476-81. PubMed ID: 15920570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]